# Section 1: Company Overview

## S1.1: Basic Information

| Field | Value |
| :---- | :---- |
| Company Name | N/A |
| Establishment Date | N/A |
| Headquarters Location | N/A |


## S1.2 : Core Competencies

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Innovation Advantages | N/A | N/A |
| Product Advantages | N/A | N/A |
| Brand Recognition | N/A | N/A |
| Reputation Ratings | N/A | N/A |


## S1.3 : Mission & Vision

| Field | Value |
| :---- | :---- |
| Mission Statement | N/A |
| Vision Statement | N/A |
| Core Values | N/A |


# Section 2: Financial Performance

## S2.1: Income Statement

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Revenue | N/A | N/A | N/A | Units | GBP |
| Cost of Goods Sold | N/A | N/A | N/A | Units | GBP |
| Gross Profit | N/A | N/A | N/A | Units | GBP |
| Operating Expense | N/A | N/A | N/A | Units | GBP |
| Operating Income | N/A | N/A | N/A | Units | GBP |
| Net Profit | N/A | N/A | N/A | Units | GBP |
| Income before income taxes | N/A | N/A | N/A | Units | GBP |
| Income tax expense(benefit) | N/A | N/A | N/A | Units | GBP |
| Interest Expense | N/A | N/A | N/A | Units | GBP |


## S2.2: Balance Sheet

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Total Assets | N/A | N/A | N/A | Units | GBP |
| Current Assets | N/A | N/A | N/A | Units | GBP |
| Non-Current Assets | N/A | N/A | N/A | Units | GBP |
| Total Liabilities | N/A | N/A | N/A | Units | GBP |
| Current Liabilities | N/A | N/A | N/A | Units | GBP |
| Non-Current Liabilities | N/A | N/A | N/A | Units | GBP |
| Shareholders' Equity | N/A | N/A | N/A | Units | GBP |
| Retained Earnings | N/A | N/A | N/A | Units | GBP |
| Total Equity and Liabilities | N/A | N/A | N/A | Units | GBP |
| Inventories | N/A | N/A | N/A | Units | GBP |
| Prepaid Expenses | N/A | N/A | N/A | Units | GBP |


## S2.3: Cash Flow Statement

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Net Cash Flow from Operations | N/A | N/A | N/A | Units | GBP |
| Net Cash Flow from Investing | N/A | N/A | N/A | Units | GBP |
| Net Cash Flow from Financing | N/A | N/A | N/A | Units | GBP |
| Net Increase/Decrease in Cash | N/A | N/A | N/A | Units | GBP |
| Dividends | N/A | N/A | N/A | Units | GBP |


## S2.4: Key Financial Metrics

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Gross Margin | N/A | N/A | N/A | Units | GBP |
| Operating Margin | N/A | N/A | N/A | Units | GBP |
| Net Profit Margin | N/A | N/A | N/A | Units | GBP |
| Current Ratio | N/A | N/A | N/A | Units | GBP |
| Quick Ratio | N/A | N/A | N/A | Units | GBP |
| Interest Coverage | N/A | N/A | N/A | Units | GBP |
| Asset Turnover | N/A | N/A | N/A | Units | GBP |
| Debt-to-Equity | N/A | N/A | N/A | Units | GBP |
| Return on Equity | N/A | N/A | N/A | Units | GBP |
| Return on Assets | N/A | N/A | N/A | Units | GBP |
| Effective Tax Rate | N/A | N/A | N/A | Units | GBP |
| Dividend Payout Ratio | N/A | N/A | N/A | Units | GBP |

## S2.5: Operating Performance

| Field | 2024 | 2023 | 2022 |
| :---- | :---- | :---- | :---- |
| Revenue by Product/Service | N/A | N/A | N/A |
| Revenue by Geographic Region | N/A | N/A | N/A |


# Section 3: Business Analysis

## S3.1: Profitability Analysis

| Field | Answer |
| :---- | :---- |
| Revenue & Direct-Cost Dynamics | N/A |
| Operating Efficiency | N/A |
| External & One-Off Impact | N/A |


## S3.2: Financial Performance Summary

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Comprehensive financial health | N/A | N/A |
| Profitability and earnings quality | N/A | N/A |
| Operational efficiency | N/A | N/A |
| Financial risk identification and early warning | N/A | N/A |
| Future financial performance projection | N/A | N/A |


## S3.3: Business Competitiveness

| Field | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Business Model | N/A | N/A |
| Market Position | N/A | N/A |


# Section 4: Risk Factors

## S4.1: Risk Factors

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Market Risks | N/A | N/A |
| Operational Risks | N/A | N/A |
| Financial Risks | N/A | N/A |
| Compliance Risks | N/A | N/A |


# Section 5: Corporate Governance

## S5.1: Board Composition
| Name | Position | Total Income |
| :---- | :---- | -----------: |
| N/A | N/A | N/A |

## S5.2: Internal Controls
| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Risk assessment procedures | N/A | N/A |
| Control activities | N/A | N/A |
| Monitoring mechanisms | N/A | N/A |
| Identified material weaknesses or deficiencies | N/A | N/A |
| Effectiveness | N/A | N/A |


# Section 6: Future Outlook

## S6.1: Strategic Direction

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Mergers and Acquisition | N/A | N/A |
| New technologies | N/A | N/A |
| Organisational Restructuring | N/A | N/A |


## S6.2: Challenges and Uncertainties

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Economic challenges such as inflation, recession risks, and shifting consumer behavior that could impact revenue and profitability. | N/A | N/A |
| Competitive pressures from both established industry players and new, disruptive market entrants that the company faces. | N/A | N/A |


## S6.3: Innovation and Development Plans

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| R&D investments, with a focus on advancing technology, improving products, and creating new solutions to cater to market trends | {'total_spending': '£131.3m', 'customer_funded': '£114.0m', 'internally_funded': {'expensed': '£14.2m', 'capitalised': '£3.1m'}, 'focus_areas': ['Sensors & Information', 'development of new products', 'automation and safety enhancements'], 'key_initiatives': [{'name': 'Joint Biological Tactical Detection System', 'investment': '£8.8m'}, {'name': 'Perceive', 'investment': '£4.3m'}]} | {'total_spending': '£113.6m', 'customer_funded_rd': '£102.0m', 'internally_funded_rd': {'expensed': '£10.1m', 'capitalised': '£1.5m'}, 'focus_areas': ['Sensors & Information', 'biotechnology', 'artificial intelligence', 'cyber and quantum computing'], 'technology_advancement_initiatives': ['Development of advanced biological detection systems', 'Investment in new product development to maintain leadership in missile and aerospace applications'], 'innovation_programs': ['Roke Academy for talent development', 'Roke Futures for technology solutions outside national security']} |
| New product launches, emphasizing the company's commitment to continuously introducing differentiated products | {'products': [{'name': 'Roke Intelligence', 'features': ['Geollect for geospatial analytics', 'Infosight for information operations', 'Intelligence Services integrating AI and data analytics'], 'market_differentiation': 'Offers integrated toolkits for faster decision-making in a dynamic risk environment.'}, {'name': 'Roke Agile Counter-UAS', 'features': ['AI-powered RapidEO sensor system for UAS threat detection', 'Open-architecture fusion and autonomy engine for sensor integration'], 'market_differentiation': 'Provides a flexible and scalable solution to counter evolving UAS threats.'}]} | {'notable_products': [{'name': 'Joint Biological Tactical Detection System (JBTDS)', 'contract_value': '$15m', 'features': 'Automated sensor for rapid detection of biological warfare agents'}, {'name': 'Enhanced Maritime Biological Detection System (EMBD)', 'contract_value': '$15.3m', 'features': 'Fully automated sensor for airborne biological warfare agents'}, {'name': 'BIOFAST TM', 'description': 'Next-generation bio threat identifier platform'}], 'market_differentiation_strategies': ['Focus on long-term contracts to secure supply', 'Leveraging advanced technology for competitive advantage in niche markets']} |
